AN OPEN-LABEL, TOLERABILITY AND EFFICACY STUDY OF ZYN002 (CANNABIDIOL) Administered As A Transdermal Gel To Children And Adolescents With 22Q11.2 Deletion Syndrome (INSPIRE)-MedSci.cn

AN OPEN-LABEL, TOLERABILITY AND EFFICACY STUDY OF ZYN002 (CANNABIDIOL) Administered As A Transdermal Gel To Children And Adolescents With 22Q11.2 Deletion Syndrome (INSPIRE)

Heussler, H; Cohen, J; Buchanan, C; O'Neill, C; Sebree, T; O'Quinn, S

JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2022; 66 (8-9): 672

科室
- - 订阅+
  - 更多科室
工具
服务